Accueil   Appels à projets   Fast Track to Innovation (FTI)

Fast Track to Innovation (FTI)

Les grandes lignes de l'appel à projets

Type de l'appel : Collaboratif

Porteur(s) de projet : ETI, Grand groupe, PME

Date d'ouverture : 7 Novembre 2017

Date de clôture : 22 Octobre 2019

Dimension : Europe

Financement :

Type de financement : Subvention

Thématique(s) médicale(s) : Toutes thématiques

Secteur(s) industriel(s) : Tout secteur

FTI supports actions undertaking innovation from the demonstration stage through to market uptake, including activities such as piloting, test-beds, systems validation in real-world working conditions, validation of business models, pre-normative research, and standard setting.

The maximum EU contribution per action is €3 million (funding rate: 70% for profit entities; 100% for not-for-profit entities).

Deadline of cut-offs

  • 23 May 2019
  • 22 October 2019

 

If your proposal involves technological innovation, your consortium should declare that the technology or the technologies concerned are at least at Technology Readiness Level (TRL) 6. The intention will be to bring the TRL up to 8 for technological innovations and to an analogous level of maturity for nontechnological innovations during the lifetime of the FTI action.

 

FTI actions are encouraged to be interdisciplinary, cutting across different sectors and technologies. Actions supporting innovative concepts that have the potential to disrupt or to create new markets are particularly welcome. In your proposal, you should:

 

  • Specify the intended outcome and describe key performance indicators and success criteria.
  • Make reference to and incorporate a business plan clearly describing the market potential, business opportunities for participants, measures to enhance the probability of eventual commercial take-up, and a credible commercialisation strategy that identifies next steps and specifies other actors to be involved.
  • Pay particular attention to IP protection and ownership and to the possibility of commercial exploitation (often known as 'freedom to operate').
  • Specify the expected impact in terms of competitiveness and growth of the business partners in the consortium, measured in terms of turnover and job creation.
  • Clearly describe the expected impact in both qualitative and quantitative terms, with factors such as time sensitivity and international competitiveness considered in the light of the technology field, innovation area and industry sectors concerned.


The time to initial market take-up should be no more than 3 years from the start of your FTI action. In very well-justified cases linked to the specific characteristics of a particular innovation field or industry sector, the time to initial market take-up could be longer.


Possible impacts on sustainability or climate change, in particular, or on other cross-cutting objectives of Horizon 2020, must be highlighted. Participation from industry in your consortium is mandatory. Universities and research and technology organisations can also participate.


Actors with an important role in commercialisation are encouraged to take part, such as cluster organisations, end-users, industry associations, incubators, investors, and the public sector. Including start-ups with groundbreaking ideas that could create new markets is encouraged.

 

Link to the Participant Portal

En poursuivant votre navigation sur notre site, vous acceptez l'utilisation des cookies et la collecte de vos données et informations personnelles par Lyonbiopôle, dans les finalités de mesurer le trafic sur le site Web, de fournir des statistiques et de vous proposer des contenus adaptés à vos centres d’intérets. Pour exercer vos droits d'accès, de rectification, d'opposition, de suppression et de portabilité, conformément au règlement général sur la protection des données (UE n°2016/679), vous etes informés que vous pouvez envoyer votre demande à dpo@lyonbiopole.com. Plus de détails sont disponibles en cliquant ici J'accepte